SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-044613
Filing Date
2010-03-01
Accepted
2010-03-01 15:42:30
Documents
9
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1080420
2 OFFER LETTER BETWEEN THE COMPANY AND CHRISTOPHER STONE dex1029.htm EX-10.29 13280
3 SUBSIDIARIES OF THE REGISTRANT dex211.htm EX-21.1 1706
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 9589
5 CERTIFICATION OF PEO PURSUANT TO RULE 13A-14(A) OR RULE 15D-14(A) dex311.htm EX-31.1 6478
6 CERTIFICATION OF PFO PURSUANT TO RULE 13A-14(A) OR RULE 15D-14(A) dex312.htm EX-31.2 6460
7 CERTIFICATION OF PEO AND PFO AS REQUIRED BY RULE 13A-14(B) OR RULE 15D-14(B) dex321.htm EX-32.1 4478
8 GRAPHIC g77569g86t08.jpg GRAPHIC 49936
9 GRAPHIC g77569g87c78.jpg GRAPHIC 6680
  Complete submission text file 0001193125-10-044613.txt   1202225
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19756 | Film No.: 10644285
SIC: 2836 Biological Products, (No Diagnostic Substances)